Sempra projects robust growth in EPS and a significant increase in regulated rate base from 2026 to 2030, driven by strategic utility investments and geographic growth, particularly in Texas.
Generated by Dafinchi AI. Source-grounded AI analysis, not investment advice.
What is Sempra's growth outlook and rate base projection for 2026-2030?
Sempra provided a progression of adjusted EPS guidance that implies sustained growth through the end of the decade: 2026 adjusted EPS: $4.80–$5.30, introduced 2027 adjusted EPS: $5.10–$5.70, and issued a 2030 EPS outlook: $6.70–$7.50. 1
Management also characterized this as one of the highest projected growth rates in the sector and stated that the 2030 outlook continues through the end of the decade. 1 They further tied the longer-run profile to the company’s stated 7%–9% growth framework (referenced as the long-term growth rate beyond the plan period), while emphasizing that the growth is not expected to be a straight line. 2
Sempra’s outlook is supported by specific near-term execution items across its operating footprint:
Sempra projected that overall rate base increases from $57 billion in 2025 to $97 billion in 2030, which management described as an 11% five-year CAGR. 5 This overall trajectory is directly connected to the company’s expanded utility-heavy capital plan. 53
Sempra stated it is launching a $65 billion capital plan for 2026–2030, an increase over the prior plan year, and that 95% of Sempra’s overall capital program is targeted for utility investments—the core driver of rate base expansion. 3
Sempra also described that this plan is primarily driven by strong growth at Sempra Texas, notably from acceleration of the Permian Basin reliability plan, alongside continued progress in the transmission expansion program and conservative base-plan assumptions for Oncor. 5
Sempra explicitly projected different growth rates by geography:
Putting the excerpts together, Sempra’s rate base outlook is anchored by:
Separately, management’s EPS outlook is consistent with this capital-to-rate-base translation, as shown by the 2026–2027 guidance ranges and the 2030 EPS range. 1 They also emphasized that improved certainty of future earnings/cash flows underpins the increased confidence to provide the 2030 outlook. 8
Disclaimer: The output generated by dafinchi.ai, a Large Language Model (LLM), may contain inaccuracies or "hallucinations." Users should independently verify the accuracy of any mathematical calculations, numerical data, and associated units, as well as the credibility of any sources cited. The developers and providers of dafinchi.ai cannot be held liable for any inaccuracies or decisions made based on the LLM's output.
Sempra confirms its full-year 2026 adjusted EPS guidance remained unchanged during Q1 2026, emphasizing consistency in its financial outlook.
Sources used
Research questionWhat guidance change did Sempra announce for Q1 2026?
Oracle’s customer prepayments, customer-provided hardware, and supplier financing can reduce how much cash Oracle must advance as RPO grows. These models change the timing and source of funding, not the need to build capacity. Management expects strong cash generation from projects after ramp-up, but gave no timeline for positive free cash flow and emphasized that infrastructure margins still depend on pricing, costs, and operating efficiency.
Sources used
Research questionHow are Oracle's prepayment, bring-your-own-hardware, and supplier-financing models changing the relationship between RPO growth, CapEx, free cash flow, and infrastructure margins?
Answer outline
Medtronic reports robust Q1 2027 base business outside CAS, led by CRM, CST, and Surgical, with Altaviva offsetting SNM softness. The Cornerstone investment is a $700 million global initiative driving long-term growth, but near-term revenue timing is not disclosed, and management reduced the operating-margin expansion guidance by about 10 bps to fund reinvestments.
Sources used
Research questionPlease provide an update on Medtronic's base business excluding CAS, including Altaviva performance, plus details on the Cornerstone deal (timing of revenue impact in base Surgical, contract structure, geographic scope including whether the U.S. is included), and the margin guidance change (clarify the rationale behind lowering the operating profit margin expansion guidance by about 10 basis points)?
Answer outline
Medtronic reports a broad-based uplift in its base business excluding CAS for Q1 FY2027, led by CRM, CST, and Surgical strengths, with Altaviva beginning to contribute as reimbursement and training efforts scale. The Cornerstone investment is framed as a longer-term, globally focused platform that may deliver revenue gradually, while the company trims near-term operating-margin expansion by ~10 basis points to fund growth initiatives. Organic revenue guidance is raised despite the investment backdrop.
Sources used
Research questionPlease provide an update on Medtronic's base business excluding CAS, including Altaviva performance, plus details on the Cornerstone deal (timing of revenue impact in base Surgical, contract structure, geographic scope including whether the U.S. is included), and the margin guidance change (clarify the rationale behind lowering the operating profit margin expansion guidance by about 10 basis points)?
Answer outline
Estée Lauder management frames margin expansion as driven mainly by SG&A efficiency and delayering, with gross margin a modest contributor and ongoing restructuring benefits flowing into 2028. They outline a cash plan centered on deleveraging, fully funded CapEx for consumer growth, and steady dividends, while affirming that transformational M&A is off the table and a 13.5% margin runway remains attainable.
Sources used
Research questionWhat did management say about Margin expansion opportunities and cash usage?
Answer outline
Public Storage's NSA back-half outlook emphasizes sustaining NOI growth through occupancy gains and expense discipline, plus micro-market pricing execution and PSNext integration momentum. The plan includes a roughly $0.02 per share core FFO financing benefit and about 14,000 incremental units online in 2H26, outlining a practical path to stronger 2H profitability.
Sources used
Research questionWhat specific metrics signify success for NSA in the back half?
Answer outline
OGE Energy frames its 17% FFO-to-debt target as a planning range rather than a quarterly constant, acknowledging normal variability through Q2 2026. The company emphasizes a broader toolkit—bridge PPAs for construction timing and CWIP financing among other capital-structure tools—to keep credit metrics near the target while projects come online, and to tolerate ebb and flow within the ~17% ZIP code.
Sources used
Research questionRegarding the 17% FFO-to-debt target, will PPAs continue to be used to manage timing or could this metric temporarily dip until projects are online?
Answer outline
Air Products states NEOM capex neutrality in fiscal 2027 with no material impact on earnings or cash flow, reflecting commissioning timing and deconsolidation mechanics. The company also outlined a ~$500 million capex timing reduction and a redeployment strategy focused on high-return industrial gas projects and electronics backlog, with buybacks considered later in the cycle.
Sources used
Research questionWhat did management say about NEOM capex neutrality and redeployment?
Answer outline
Management reaffirmed that Signature transition spend remains on plan with similar levels into 2027, while maintaining an approximate $9 billion operating free cash flow outlook for 2026, weighted toward the back half due to timing.
Sources used
Research questionWhat did management say about Signature transition spend and FCF outlook?
Answer outline
Simon Property Group’s Q2 2026 discussion clarifies that long-term NOI/FFO growth can outpace FAD, driven by leasing and tenant-reinvesment efforts, while near-term cash flows may reflect reinvestment costs. Management signals ongoing reinvestment and disciplined capital allocation through Q4 2026, supported by strong liquidity and a robust development pipeline.
Sources used
Research questionHow should investors interpret the apparent difference between long-term NOI/FFO growth outpacing FAD growth versus the year-to-date trend, and what does management say that implies for cash-flow priorities through Q4 2026?
Answer outline
Disney explains that Experiences ROIC has improved over time and is expected to stay strong, driven by disciplined project selection based on attractive returns and enhanced guest value. Execution sequencing is mostly limited by operational factors like shipyard capacity, ensuring new capacity comes online when feasible while maintaining strong returns and ongoing guest and margin gains, supported by a pipeline of major site expansions.
Sources used
Research questionWhat did management say about the drivers of Experiences ROIC over time, including how project selection criteria and operational constraints (e.g., shipyard capacity) affect the sequencing and expected returns of new capacity?
Answer outline
Disney Experiences delivered 4% global guest growth and 3% domestic attendance in Q3, supported by a 4% rise in per-cap spending and a mix of targeted promotions that protected yield. Management outlined a balanced growth framework for the next two years, emphasizing disciplined capital allocation, strategic capacity expansion across parks and Disney Cruise Line, and cost-management measures to sustain margins while serving more guests.
Sources used
Research questionHow did Disney Experiences achieve 4% global guest growth and 3% domestic attendance growth in Q3, and what specific levers did management cite for balancing yield versus volume during the next couple of years of parks and cruise capacity expansion?
Answer outline
Dafinchi